Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction between the U.S. and Isomeric Pharmacy Solutions, two of the company’s co-owners and COO.
read more
Wednesday, April 17, 2019
Fibrocell announced a collaboration agreement with Castle Creek to develop and commercialize FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
read more
Thursday, September 08, 2022
Flagship Biosciences announced the acquisition of Interpace Pharma Solutions ("IPS"), a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions.
read more
Flamma announced the ground breaking for their new R&D building.
read more
Friday, November 13, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury supply chain.
read more
The Flamma Group, a company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry as well as a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) ...
read more
Friday, November 06, 2020
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain.
read more
The Russian pharmaceutical market is developing rapidly; it takes 11th place in the rating of pharmaceutical market volumes worldwide and is predicted to go up to 9th place by 2016. Along with its growing potential, important changes in the industry ...
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Wednesday, October 23, 2019
Foamix has entered into a long term contract manufacturing and supply agreement with ASM for AMZEEQ™ topical foam, 4%.
read more
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy ...
read more
Wednesday, September 08, 2021
For over 20 years, Formulated Solutions has been driven to create more ideal consumer and patient experiences in Pharmaceutical and Self-Directed Consumer Healthcare. In support of that adherence-focused mission, Formulated Solutions is proud to ...
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
Kabi, a leading provider of infusion therapy and clinical nutrition, and Fenwal Inc. a global leader specializing in separation technologies for blood and cell collection and therapy, announced today a definitive agreement for Fresenius Kabi to ...
read more
Tuesday, November 21, 2017
Fresenius Kabi will expand its manufacturing operations in Wilson County, Governor Roy Cooper announced.
read more